Enhancing access to innovative
pharmaceutical products with HEOR

Today’s clinical development process includes additional steps that include communicating the value proposition, demonstrating clinical and economic evidence to a multitude of stakeholders: private payers, providers, entire health systems, HTA agencies, PBMs, etc. 

Demonstrating the value of your innovations to these audiences is critical to define economic value and maxime patient access. Stage Analytics’ health economics and outcomes research (HEOR) is your thinking partner to work alongside you throughout this process.

Helping our clients achieve their goals

We empower our clients with the data and insights to establish your value narrative. Through our HEOR services, we support clients in the development, execution, and dissemination of the clinical and economic evidence to ensure effective patient access.

Our team of experienced health economists, epidemiologists, and data scientists have significant experience in applying advanced economic methods to effectively capture all dimensions of value of healthcare innovations. We work with our clients to ensure that the manufacturers effectively communicate value and maximize patient access.

Our services also include support to ICER reviews and engagement with health technology assessment agencies for US-based and international clients, to optimize performance and increase the likelihood of approval.

Get industry insights and Stage Analytics news in your inbox!

Sign up for our monthly email newsletter.

Our HEOR services include but are not limited to:

Pre-approval

Post-approval

Evidence strategic plans
Burden of illness
Early cost-effectiveness modeling and scenario analysis
Quantification of market size and unmet medical need
Identification of outcome research endpoints​
Cost-effectiveness analysis alongside clinical trials
Patient-reported outcomes
Support for ICER and HTA reviews
Budget impact models
Economic evaluation
Real-world evidence generation plans
Real-world evidence studies
Payer engagement support

Our HEOR services include but are not limited to:

Pre-approval

Phase 1 - Phase 3

Evidence Strategic Plans

Phase 1 - Phase 3

Burden of Illness

Phase 1 - Phase 2

Early cost-effectiveness modeling and scenario analysis​

Phase 1 - Phase 2

Quantification of market size and unmet medical need

Phase 2 - Phase 3

Identification of outcome research endpoints​

Phase 2 - Phase 3

Cost-effectiveness analysis alongside clinical trials

Phase 3

Patient-reported outcomes

Phase 4

Support for ICER and HTA reviews

Phase 4

Budget impact models

Phase 4

Economic evaluation

Phase 4

Real-world evidence generation plans

Phase 4

Real-world evidence studies

Phase 4

Payer engagement support

Post-approval

Phase 4

Evidence Strategic Plans

Phase 4

Burden of Illness

Phase 4

Patient-reported outcomes

Phase 4

Support for ICER and HTA reviews

Phase 4

Budget impact models

Phase 4

Economic evaluation

Phase 4

Real-world evidence generation plans

Phase 4

Real-world evidence studies

Phase 4

Payer engagement support

Stage Analytics
Stage Analytics

Get industry insights and Stage Analytics news in your inbox!

Sign up for our monthly email newsletter.

Skip to content